Advertisement

Classification and Mechanism of Action of the Cardiac Inotropic Agents: An Overview

  • Adawia A. Alousi
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 68)

Abstract

The cardiac inotropic agents are substances that modify cardiac muscle contraction by acting directly on the myocardium (1). These agents could be categorized into two major classes; positive inotropic agents that stimulate cardiac muscle contraction such as the cardiac glycosides (2), the catecholamines (3) and the bipyridines (4), and negative inotropic agents that depress cardiac contraction such as the β-adrenergic blockers, the antiarrhythmics and the barbiturates (5).

Keywords

Adenylate Cyclase Acute Heart Failure Cardiac Glycoside Inotropic Agent Digitalis Glycoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alousi, A.A. and Farah, A.E., Trend Pharmacol. Sci. 1: 143–146, 1980.CrossRefGoogle Scholar
  2. 2.
    Grupp, G., Grupp, I.L., Hickerson, T., Lee, S.W. and Schwartz, A. In: Cardiac Glycosides 1785-1985. (Eds. E. Erdmann, K. Greef and J.C. Skou), Stinkopff Verlag Darmstadt, Springer-Verlag, New York, 1986, pp. 99–108.Google Scholar
  3. 3.
    Scholtz, H. In: Handbook of Experimental Pharmacology, Adrenergic Activators and Inhibitors, (Ed. L. Szekeres), Springer-Verlag, Berlin/ Heidelberg/New York, 54(1): 651–733, 1980.Google Scholar
  4. 4.
    Alousi, A.A., Fabian, R.J., Baker, J.F. and Stroshane, R.M. In: New Drugs Annual: Cardiovascular Drugs (Ed. A. Scriabine), Raven Press, New York, 3:245–283, 1985.Google Scholar
  5. 5.
    Alousi, A.A., Canter, J.M. and Fort, D.J. Cardiovas. Res. 19: 483–494, 1985.CrossRefGoogle Scholar
  6. 6.
    Braunwald, E. In: Heart Disease (Ed. E. Braunwald), W.B. Saunders Comp., Philadelphia, London, Toronto, 1984, pp. 453–471.Google Scholar
  7. 7.
    Colucci, W.S., Wright, R.F. and Braunwald, E. New. Engl. J. Med. 314: 349–358, 1986.PubMedCrossRefGoogle Scholar
  8. 8.
    Goldberg, L.I. Pharmacol. Rev. 24: 1–29, 1972.PubMedGoogle Scholar
  9. 9.
    Tuttle, R.R., Mills, J. Circ. Res. 36: 185–196, 1975.PubMedGoogle Scholar
  10. 10.
    Katz, A. In: Physiology of the Heart (Ed. A. Katz), Raven Press, 1977, pp. 107–119.Google Scholar
  11. 11.
    Stull, J.T. and Mayer, S.E. In: Handbook of Physiology, The Cardiovascular System, Vol. I. The Heart. (Eds. R.M. Berne, N. Sperelakis and S.R. Geiger). The Physiological Soc., Bethesda, Maryland, 1979, pp. 741–774.Google Scholar
  12. 12.
    Ruegg, J.C. Cir. Res. Supp. 73: III, 78–84, 1986.Google Scholar
  13. 13.
    Hoh, J.F.Y., McGrath, P.A. and Hale, P.T. J. Mol. Cell. Cardiol. 10: 1053–1076, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    Pagani, E.D. and Julian, F.J. Circ. Res. 54: 586–594, 1984.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Adawia A. Alousi
    • 1
  1. 1.Molecular Cardiology UnitSterling-Winthrop Research InstituteRensselaerUSA

Personalised recommendations